Vascular galectins: Regulators of tumor progression and targets for cancer therapy
- 1 December 2013
- journal article
- review article
- Published by Elsevier BV in Cytokine & Growth Factor Reviews
- Vol. 24 (6), 547-558
- https://doi.org/10.1016/j.cytogfr.2013.07.003
Abstract
No abstract availableKeywords
Funding Information
- Dutch Cancer Society
This publication has 97 references indexed in Scilit:
- Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entryProceedings of the National Academy of Sciences of the United States of America, 2011
- Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stressAngiogenesis, 2011
- Dynamics of galectin-3 in the nucleus and cytoplasmBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Cleavage of galectin‐3 by matrix metalloproteases induces angiogenesis in breast cancerInternational Journal of Cancer, 2010
- Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?Angiogenesis, 2009
- Galectin-8 interacts with podoplanin and modulates lymphatic endothelial cell functionsExperimental Cell Research, 2009
- Galectin–glycan lattices regulate cell-surface glycoprotein organization and signallingBiochemical Society Transactions, 2008
- Functions of cell surface galectin-glycoprotein latticesCurrent Opinion in Structural Biology, 2007
- Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapyProceedings of the National Academy of Sciences of the United States of America, 2006
- Lewis x Antigen Mediates Adhesion of Human Breast Carcinoma Cells to Activated Endothelium. Possible Involvement of the Endothelial Scavenger Receptor C-type LectinBreast Cancer Research and Treatment, 2006